Cerebrolysin and Recovery After Stroke (CARS): A randomized, placebo-controlled, double-blind, multicenter trial

Stroke

Volumn 47, Issue 1, 2016, Pages 151-159

  Muresanu, Dafin F ^a,i   Heiss, Wolf Dieter ^b   Hoemberg, Volker ^c   Bajenaru, Ovidiu ^d   Popescu, Cristian Dinu ^e   Vester, Johannes C ^f   Rahlfs, Volker W ^f   Doppler, Edith ^g   Meier, Dieter ^g   Moessler, Herbert ^g   Guekht, Alla ^h  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c SHR Gesundheitszentrum Bad Wimpfen GmbH   (Germany)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f IDV Data Analysis and Study Planning ^*  (Germany)

^g EVER Neuro Pharma GmbH   (Austria)

^h PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

ⁱ RoNeuro Institute for Neurological Research and Diagnostic   (Romania)

Author keywords

Cerebrolysin; randomized, double blind, placebo controlled trial; recovery of function; rehabilitation; stroke

Indexed keywords

CEREBROLYSIN; NEUROPROTECTIVE AGENT; PLACEBO; AMINO ACID;

ACTION RESEARCH ARM TEST SCORE; ACUTE HEART INFARCTION; ADULT; ARM MOVEMENT; ARTERIOSCLEROSIS; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CONVALESCENCE; CYTOLYTIC HEPATITIS; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EFFECT SIZE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; KIDNEY COLIC; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTOR PERFORMANCE; MULTICENTER STUDY; PARALLEL DESIGN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STROKE PATIENT; TREATMENT DURATION; UPPER ABDOMINAL PAIN; URINARY TRACT INFECTION; AGED; CLINICAL TRIAL; DRUG EFFECTS; PHASE 2 CLINICAL TRIAL; STROKE; TREATMENT OUTCOME;

AGED; AMINO ACIDS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84952630242     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009416     Document Type: Article

References (59)

1. Murray CJ, Lopez AD., Measuring the global burden of disease. N Engl J Med 2013 369 448 457. doi: 10.1056/NEJMra1201534
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 380 2095 2128. doi: 10.1016/S0140-6736(12)61728-0.
3. Wardlaw JM, Murray V, Berge E, del Zoppo GJ., Thrombolysis for acute ischemic stroke, update August 2014. Stroke 2014 45 e222 e225. doi: 10.1161/STROKEAHA.114.007024.
4. Pierot L, Soize S, Benaissa A, Wakhloo AK., Techniques for endovascular treatment of acute ischemic stroke: from intra-Arterial fibrinolytics to stent-retrievers. Stroke 2015 46 909 914. doi: 10.1161/STROKEAHA.114.007935
5. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015 372 11 20. doi: 10.1056/NEJMoa1411587
6. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015 372 1009 1018. doi: 10.1056/NEJMoa1414792
7. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015 372 1019 1030. doi: 10.1056/NEJMoa1414905
8. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Zhao X, GWTG-Stroke Steering Committee and Investigators The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke 2010 41 1431 1439. doi: 10.1161/STROKEAHA.110.583815
9. Zahuranec DB, Majersik JJ., Percentage of acute stroke patients eligible for endovascular treatment. Neurology 2012 79 13 suppl 1 S22 S25. doi: 10.1212/WNL.0b013e31826957cf
10. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW., 1,026 experimental treatments in acute stroke. Ann Neurol 2006 59 467 477. doi: 10.1002/ana.20741
11. Kaur H, Prakash A, Medhi B., Drug therapy in stroke: from preclinical to clinical studies. Pharmacology 2013 92 324 334. doi: 10.1159/000356320
12. Xu SY, Pan SY., The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res 2013 19 37 45
13. Tymianski M., Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke 2013 44 2942 2950. doi: 10.1161/STROKEAHA.113.000731
14. Hossmann KA., The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab 2012 32 1310 1316. doi: 10.1038/jcbfm.2011.186
15. Masliah E, Díez-Tejedor E., The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today 2012 48 suppl A 3 24. doi: 10.1358/dot.2012.48(Suppl.A).1739716
16. Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M., Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm (Vienna) 2001 108 459 473
17. Zhang L, Chopp M, Meier DH, Winter S, Wang L, Szalad A, Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke 2013 44 1965 1972. doi: 10.1161/STROKEAHA.111.000831
18. Gutmann B, Hutter-Paier B, Skofitsch G, Windisch M, Gmeinbauer R., In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res 2002 4 59 65. doi: 10.1080/10298420290007637
19. Darsalia V, Heldmann U, Lindvall O, Kokaia Z., Stroke-induced neurogenesis in aged brain. Stroke 2005 36 1790 1795. doi: 10.1161/01.STR.0000173151.36031.be
20. Muresanu DF, Buzoianu A, Florian SI, von Wild T., Towards a roadmap in brain protection and recovery. J Cell Mol Med 2012 16 2861 2871. doi: 10.1111/j.1582-4934.2012.01605.x
21. Ren J, Sietsma D, Qiu S, Moessler H, Finklestein SP., Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor Neurol Neurosci 2007 25 25 31
22. Hanson LR, Liu XF, Ross TM, Doppler E, Zimmermann-Meinzingen S, Moessler H, Cerebrolysin reduces infarct volume in a rat model of focal cerebral ischemic damage. Am J Neuroprotect Neuroregen 2009 1 60 66. doi: 10.1166/ajnn.2009.1010
23. Zhang C, Chopp M, Cui Y, Wang L, Zhang R, Zhang L, Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res 2010 88 3275 3281. doi: 10.1002/jnr.22495
24. Skvortsova VI, Stakhovskaia LV, Gubski LV, Shamalov NA, Tikhonova IV, Smychkov AS., A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke. Zh Nevropatol Psikhiatr im S S Korsakova. 2004 S11 51 55
25. Ladurner G, Kalvach P, Moessler H, Cerebrolysin Study Group Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm (Vienna) 2005 112 415 428. doi: 10.1007/s00702-004-0248-2
26. Ziganshina LE, Abakumova T, Kuchaeva A., Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev 2010 4 CD007026. doi: 10.1002/14651858.CD007026.pub2.
27. Lang W, Stadler CH, Poljakovic Z, Fleet D, Lyse Study Group A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Int J Stroke 2013 8 95 104. doi: 10.1111/j.1747-4949.2012.00901.x
28. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke 2012 43 630 636. doi: 10.1161/STROKEAHA.111.628537
29. Rogalewski A, Schneider A, Ringelstein EB, Schäbitz WR., Toward a multimodal neuroprotective treatment of stroke. Stroke 2006 37 1129 1136. doi: 10.1161/01.STR.0000209330.73175.34
30. Muresanu DF., Neuromodulation with pleiotropic and multimodal drugs-future approaches to treatment of neurological disorders. Acta Neurochir Suppl 2010 106 291 294. doi: 10.1007/978-3-211-98811-4-54
31. Stan AD, Bədişor A, Bîrle C, Blesneag AV, Opincariu I, Iancu M, The influence of neurotrophic factors treatment on stroke volume. Ro J Neurol 2013 3 124 129
32. Lyle RC., A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981 4 483 492. doi: 10.1097/00004356-198112000-00001
33. Posteraro L, Formis A, Grassi E, Bighi M, Nati P, Proietti Bocchini C, Quality of life and aphasia. Multicentric standardization of a questionnaire. Eura Medicophys 2006 42 227 230
34. Goodglass H, Kaplan E., The Assessment of Aphasia and Related Disorders 1983 2nd Philadelphia, PA Lea & Febiger
35. D'Agostino RB, Campbell M, Greenhouse J., The Mann-Whitney statistic: continuous use and discovery. Statist Med 2006 25 541 542. doi: 10.1002/sim.2508
36. Rothmann MD, Wiens BL, Chan IS., Rothmann MD, Wiens BL, Chan IS, Chapter 12.5: Ordinal data. In: Design and Analysis of Non-Inferiority Trials 2011 Boca Raton, FL Chapman & Hall/CRC 353 356
37. Munzel U, Hauschke D., A nonparametric test for proving non-inferiority in clinical trials with ordered categorical data. Pharmaceut Statist 2003 2 31 37. doi: 10.1002/pst.17
38. Kieser M, Friede T, Gondan M., Assessment of statistical significance and clinical relevance. Stat Med 2013 32 1707 1719. doi: 10.1002/sim.5634
39. Cohen J., Statistical Power Analysis for the Behavioral Sciences 1988 2nd Hillsdale, NJ Lawrence Erlbaum Associates
40. Colditz GA, Miller JN, Mosteller F., Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int J Technol Assess Health Care 1988 4 637 642. doi: 10.1017/S0266462300007728
41. Whitehead J, Branson M, Todd S., A combined score test for binary and ordinal endpoints from clinical trials. Stat Med 2010 29 521 532. doi: 10.1002/sim.3822
42. Lu M, Tilley BC, NINDS t-PA Stroke Trial Study Group Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial. Stat Med 2001 20 1891 1901. doi: 10.1002/sim.841
43. Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1996 27 2136 2142
44. Wei LJ, Lachin JM., Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984 79 653 661. doi: 10.1080/01621459.1984.10478093
45. Lachin JM., Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Stat Med 1992 11 1151 1170. doi: 10.1002/sim.4780110903
46. Tamhane A, Dmitrienko A., Dmitrienko A, Tamhane AC, Bretz F, Analysis of multiple endpoints in clinical trials 2009 131 Boca Raton, FL: Chapman & Hall/CRC In: Multiple Testing Problems in Pharmaceutical Statistics. 163
47. Chang BS, Lowenstein DH, Quality Standards Subcommittee of the American Academy of Neurology Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003 60 10 16
48. Biester K, Lange S, Kaiser T, Potthast R., High dropout rates in trials included in Cochrane reviews. Paper Presented at: XIV Cochrane Colloquium 2006 Dublin, Ireland
49. Higgins JP, Altman DG, Sterne JA., Higgins JP, Green S, Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed January 13, 2015.
50. Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G., A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke 2008 39 390 396. doi: 10.1161/STROKEAHA.107.492363
51. Cumming TB, Thrift AG, Collier JM, Churilov L, Dewey HM, Donnan GA, Very early mobilization after stroke fast-Tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke 2011 42 153 158. doi: 10.1161/STROKEAHA.110.594598
52. Craig LE, Bernhardt J, Langhorne P, Wu O., Early mobilization after stroke: an example of an individual patient data meta-Analysis of a complex intervention. Stroke 2010 41 2632 2636. doi: 10.1161/STROKEAHA.110.588244
53. Sundseth A, Thommessen B, Rønning OM., Outcome after mobilization within 24 hours of acute stroke: a randomized controlled trial. Stroke 2012 43 2389 2394. doi: 10.1161/STROKEAHA.111.646687
54. Diserens K, Moreira T, Hirt L, Faouzi M, Grujic J, Bieler G, Early mobilization out of bed after ischaemic stroke reduces severe complications but not cerebral blood flow: a randomized controlled pilot trial. Clin Rehabil 2012 26 451 459. doi: 10.1177/0269215511425541
55. Bernhardt J, Thuy MN, Collier JM, Legg LA., Very early versus delayed mobilisation after stroke. Cochrane Database Syst Rev 2009 21 CD006187. doi: 10.1002/14651858.CD006187.pub2
56. Kwakkel G, van Peppen R, Wagenaar RC, Wood Dauphinee S, Richards C, Ashburn A, Effects of augmented exercise therapy time after stroke: a meta-Analysis. Stroke 2004 35 2529 2539. doi: 10.1161/01.STR.0000143153.76460.7d
57. Hsieh CL, Hsueh IP, Chiang FM, Lin PH., Inter-rater reliability and validity of the action research arm test in stroke patients. Age Ageing 1998 27 107 113
58. Platz T, Pinkowski C, van Wijck F, Kim IH, di Bella P, Johnson G., Reliability and validity of arm function assessment with standardized guidelines for the Fugl-Meyer Test, Action Research Arm Test and Box and Block Test: a multicentre study. Clin Rehabil 2005 19 404 411
59. Yozbatiran N, Der-Yeghiaian L, Cramer SC., A standardized approach to performing the action research arm test. Neurorehabil Neural Repair 2008 22 78 90. doi: 10.1177/1545968307305353